CClinicalTrials.gg
Status unknownNCT05004922Updated Aug 13, 2021

Site of Embryo Transfer in Intracytoplasmic Sperm Injection

An observational study in Infertility, sponsored by National Research Centre, Egypt. Status unknown. Open to female participants aged 20 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-13.

Sponsored by National Research Centre, Egypt · Observational

The sponsor has not verified this record recently (last verified Aug 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
60
Ages
20 Years to 45 Years
Sex
Female
01

Study summary

The technique of embryo transfer is thought to affect the implantation and pregnancy rate .At present, the implantation site can be estimated from the location of the very early gestational sac by transvaginal ultrasound.

Read the detailed description

Many authors claimed that an increase in implantation and pregnancy rates has been reported to occur when embryos are transferred to the central area of the uterine cavity but there are no studies about the implantation site after using this type of transfer.

02

Conditions studied

  • Infertility

Browse trials for

03

In context

Infertility

2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.

This study's planned enrollment of 60 is below the median of 200 across 714 observational studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

National Research Centre, Egypt is the lead sponsor of 49 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

infertile women

Inclusion criteria

  • 1- AVF uterus. 2- BMI less than 30

Exclusion criteria

Exclusion Criteria:

  • 1- RVF uterus. 2- BMI more than 30.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • ICSI in upper cavity

    Embryo transfer into the upper cavity

    Other: Embryo transfer into upper cavity

  • ICSI in midcavity

    Embryo transfer into the midcavity

    Other: Embryo transfer into midcavity

Interventions

  • OtherEmbryo transfer into upper cavity

    Transfer of embryos in upper cavity

    Also known as: Gestational sac site after embryo transfer

  • OtherEmbryo transfer into midcavity

    Transfer of embryos in mid cavity

    Also known as: Gestational sac site after embryo transfer

06

What researchers measure

Primary outcomes

  1. number of women who will get pregnant in each group

    how many women will get pregnant after ICSI in every group

    Time frame: within one month

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05004922
Lead sponsor
National Research Centre, Egypt
Responsible party
Sherif Elsirgany (Researcher ,Family Planning and Reproductive Health Department, National Research Centre, Egypt) — Principal investigator
First posted
Aug 13, 2021
Start date
Sep 1, 2021 (estimated)
Primary completion
Jan 1, 2022 (estimated)
Completion
Feb 1, 2022 (estimated)
Last update
Aug 13, 2021

Study contacts

Sherif Elsirgany, M.D
Contact
sherifelsirgany@yahoo.com
+201223607191
Sherif Elsirgany, M.D
principal investigator · Researcher, Family planning and Reproductive Health Department, NRC, Egypt

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion